BioNTech SE ADR buy Sargnagel
Start price
08.09.21
/
60%
€289.50
Target price
08.09.22
€333.00
Performance (%)
-49.48%
End price
09.09.22
€146.25
Summary
This prediction ended on 09.09.22 with a price of €146.25. Massive losses of -49.48% were the result for the BUY prediction by Sargnagel. Sargnagel has 60% into this prediction This prediction was marked as speculative and is excluded from Sargnagel's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
iShares Core DAX® | 2.149% | 5.415% | 21.385% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% |
According to Sargnagel what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
Innovative
Known brand
Top 10 in its market
Standard Investments for future growth
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Some uniques
Cons
Higher risks for its business
Comments by Sargnagel for this prediction
In the thread Biontech SE diskutieren
Buy BioNTech SE ADR
Kursziel gesetzt auf 333,0
In the thread Trading Biontech SE
Die von Sargnagel gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Sargnagel for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€337.70
05.08.21
05.08.21
-
05.08.22
05.08.22
-14.27%
08.09.21
08.09.21
Could be worthwhile Investment >10% per year
Capable Management
Growths faster than the competition
Higher risks for its business